Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PILDI
NCT06923787Phase 2Recruiting
- Sponsor
- Institute of Oncology Ljubljana
- Start
- Feb 2026
- Primary completion
- Jul 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Lidocaine Hydrochloride Injection, without epinephrine in colon cancer, sponsored by Institute of Oncology Ljubljana. Started Feb 2026; status: recruiting.
02
Drugs
Lidocaine Hydrochloride Injection, without epinephrine
03
Conditions
colon cancer
Beyond the preview
Go deeper on NCT06923787.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06923787.